The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
about
Trial Watch-Immunostimulation with cytokines in cancer therapyPhosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low NeurotoxicityDifferential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell linesReduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-ACorosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway.EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists.The role of hypoxia-inducible factor-1α in radiation-induced autophagic cell death in breast cancer cells.
P2860
Q28078725-91767DC2-9FD1-403A-B397-6E499A9F5DA4Q28551654-62D37FCB-5F9A-4B7D-8816-4CBBB5547333Q34654398-526DE754-57D2-4EFA-A9AD-290EA84114D5Q35067942-BA553FF7-73E0-4666-9E84-CB8E90050C9AQ35610912-155A8904-54B1-4B7F-8307-A6FF100F0F59Q35833138-AF913A77-68CF-4727-8697-8733156DBF96Q36653897-7B609C13-4228-41B5-B2A7-E28F3EB09A25Q37109719-80B78218-1EBF-486D-9941-E398A649A998Q37109919-82B00435-942E-4ACC-AFAB-875E2C0826A6Q38504154-15022011-4D83-4B98-B05A-B45F78A531FBQ51640674-CC8252E7-E398-475D-B7D0-39DEFBEF973B
P2860
The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@ast
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@en
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@nl
type
label
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@ast
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@en
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@nl
prefLabel
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@ast
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@en
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@nl
P2093
P2860
P356
P1433
P1476
The antihypertension drug doxa ...... nd VEGF and HIF-1α expression.
@en
P2093
Boh-Ram Kim
Dae-Yong Kim
Mi Sun Park
Seung Bae Rho
Seung Myung Dong
Seung-Hoon Lee
P2860
P304
P356
10.18632/ONCOTARGET.2064
P407
P577
2014-07-01T00:00:00Z